iGlarLixi, Insulin glargine and Lixisenatide fixed-ratio combination, in older adults with type 2 diabetes: efficacy and safety
A study has assessed the efficacy and safety of iGlarLixi ( a titratable, fixed-ratio combination of Insulin glargine [ iGlar...
The aims of the study were to investigate weight loss and glycemic control parameters after different bariatric surgical procedures in...
A study has investigated the prevalence and potential incremental prognostic value of combined free light chains ( cFLCs ) in...
Obese patients with uncontrolled type 2 diabetes, 3 years of intensive medical therapy plus bariatric surgery
In short-term randomized trials ( duration, 1 to 2 years ), bariatric surgery has been associated with improvement in type...
Empagliflozin is an oral selective SGLT-2 inhibitor that acts by blocking the reabsorption of glucose in the proximal tubules in...
Myocardial infarction in patients without diabetes mellitus: Metformin does not improve left ventricular ejection fraction after 4 months
Metformin ( Glucophage ) treatment is associated with improved outcome after myocardial infarction in patients with diabetes mellitus. In animal...
New research published in Diabetologia, the journal of the European Association for the Study of Diabetes ( EASD ), has...
Metformin ( Glucophage ) is the only first-line oral hypoglycaemic drug for type 2 diabetes recommended by international guidelines with...
Lixisenatide plus oral antidiabetics improves glycemic control in older patients inadequately controlled on oral antidiabetics
The efficacy and safety of Lixisenatide ( Lyxumia ), a once-daily prandial glucagon-like peptide-1 ( GLP-1 ) receptor agonist, in...
Diabetes is a risk factor for dementia. It is unknown whether higher glucose levels increase the risk of dementia in...
- Gad Anxiety
- Gallbladder Disease
- Gardenia Extract
- Gastric Adenocarcinoma
- Gastric Cancer
- Gastrointestinal Bleeding
- Gastrointestinal Stromal Tumor
- Gastro-Oesophageal Junction Adenocarcinoma
- Gaucher Disease